Patents by Inventor Roderick E. M. Scott

Roderick E. M. Scott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9863934
    Abstract: The present invention provides methods for identifying cognitive enhancers able to enhance CREB pathway function. Cognitive enhancers identified in accordance with the invention can be used in rehabilitating an animal with cognitive dysfunction and for enhancing memory or normal cognitive performance (ability or function) in the animal.
    Type: Grant
    Filed: February 1, 2016
    Date of Patent: January 9, 2018
    Assignee: Dart Neuroscience (Cayman) Ltd.
    Inventors: Timothy P. Tully, Roderick E. M. Scott, Rusiko Bourtchouladze
  • Patent number: 8791137
    Abstract: The invention provides a compound of formula I: wherein R1-R6, X, Y, and B have any of the values described herein, as well as salts of such compounds, compositions comprising such compounds, and therapeutic methods that comprise the administration of such compounds. The compounds are inhibitors of MAO-B enzyme function and are useful for improving cognitive function and for treating psychiatric disorders in animals.
    Type: Grant
    Filed: August 3, 2010
    Date of Patent: July 29, 2014
    Assignee: Dart Neuroscience (Cayman) Ltd.
    Inventors: Xianbo Zhou, Roderick E. M. Scott, Rusiko Bourtchouladze, Alan P Kaplan, Terence P Keenan, Andrew McRiner
  • Patent number: 8771935
    Abstract: The present invention provides methods for identifying cognitive enhancers able to enhance CREB pathway function. Cognitive enhancers identified in accordance with the invention can be used in rehabilitating an animal with cognitive dysfunction and for enhancing memory or normal cognitive performance (ability or function) in the animal.
    Type: Grant
    Filed: February 2, 2012
    Date of Patent: July 8, 2014
    Assignee: Dart Neuroscience (Cayman) Ltd.
    Inventors: Timothy P Tully, Roderick E. M. Scott, Rusiko Bourtchouladze
  • Patent number: 8399487
    Abstract: The invention provides a compound of formula I: wherein R1-R6, X, Y, and B have any of the values described herein, as well as salts of such compounds, compositions comprising such compounds, and therapeutic methods that comprise the administration of such compounds. The compounds are inhibitors of MAO-B enzyme function and are useful for improving cognitive function and for treating psychiatric disorders in animals.
    Type: Grant
    Filed: December 22, 2010
    Date of Patent: March 19, 2013
    Assignee: Dart NeuroScience (Cayman) Ltd.
    Inventors: Xianbo Zhou, Roderick E. M. Scott, Rusiko Bourtchouladze, Alan P. Kaplan, Terence P. Keenan, Andrew McRiner
  • Patent number: 8124330
    Abstract: The present invention provides methods for identifying cognitive enhancers able to enhance CREB pathway function. Cognitive enhancers identified in accordance with the invention can be used in rehabilitating an animal with cognitive dysfunctions and for enhancing memory or normal cognitive performance (ability or function) in a normal animal.
    Type: Grant
    Filed: August 19, 2003
    Date of Patent: February 28, 2012
    Assignee: Helicon Therapeutics, Inc.
    Inventors: Timothy P. Tully, Roderick E. M. Scott, Rusiko Bourtchouladze
  • Patent number: 8066972
    Abstract: The present invention provides methods for screening a pharmaceutical agent for its ability to modulate long term memory formation, performance of a hippocampal-dependent cognitive task or STAUFEN function. The present invention also provides methods for modulating long term memory formation or performance of a hippocampal-dependent cognitive task by modulating staufen-dependent protein expression. The present invention further provides methods for treating a defect in long term memory formation associated with a defect in STAUFEN and methods for treating a defect in performance of a hippocampal-dependent cognitive task associated with a defect in STAUFEN.
    Type: Grant
    Filed: July 15, 2008
    Date of Patent: November 29, 2011
    Assignee: Helicon Therapeutics, Inc.
    Inventors: Timothy P. Tully, Roderick E. M. Scott, Rusiko Bourtchouladze
  • Patent number: 7919626
    Abstract: The invention provides a compound of formula I: wherein R1-R6, X, Y, and B have any of the values described herein, as well as salts of such compounds, compositions comprising such compounds, and therapeutic methods that comprise the administration of such compounds. The compounds are inhibitors of MAO-B enzyme function and are useful for improving cognitive function and for treating psychiatric disorders in animals.
    Type: Grant
    Filed: February 27, 2007
    Date of Patent: April 5, 2011
    Assignee: Helicon Therapeutics, Inc.
    Inventors: Xianbo Zhou, Roderick E. M. Scott, Rusiko Bourtchouladze, Alan P. Kaplan, Terence P. Keenan, Andrew McRiner
  • Publication number: 20110044955
    Abstract: The present invention provides cell-based screening methods for identifying pharmaceutical agents which are capable of modulating (have the ability to modulate) STAUFEN function by screening for STAUFEN function.
    Type: Application
    Filed: November 20, 2009
    Publication date: February 24, 2011
    Inventors: TIMOTHY P. TULLY, RODERICK E. M. SCOTT, RUSIKO BOURTCHOULADZE
  • Publication number: 20100317648
    Abstract: The invention provides a compound of formula I: wherein R1-R6, X, Y, and B have any of the values described herein, as well as salts of such compounds, compositions comprising such compounds, and therapeutic methods that comprise the administration of such compounds. The compounds are inhibitors of MAO-B enzyme function and are useful for improving cognitive function and for treating psychiatric disorders in animals.
    Type: Application
    Filed: August 3, 2010
    Publication date: December 16, 2010
    Inventors: Xianbo Zhou, Roderick E. M. Scott, Rusiko Bourtchouladze, Alan P. Kaplan, Terence P. Keenan, Andrew McRiner
  • Patent number: 7622257
    Abstract: The present invention provides cell-based screening methods for identifying pharmaceutical agents which are capable of modulating (have the ability to modulate) STAUFEN function by screening for STAUFEN function.
    Type: Grant
    Filed: January 31, 2008
    Date of Patent: November 24, 2009
    Assignee: Helicon Therapeutics, Inc.
    Inventors: Timothy P. Tully, Roderick E. M. Scott, Rusiko Bourtchouladze
  • Publication number: 20080160534
    Abstract: The present invention provides cell-based screening methods for identifying pharmaceutical agents which are capable of modulating (have the ability to modulate) STAUFEN function by screening for STAUFEN function.
    Type: Application
    Filed: January 31, 2008
    Publication date: July 3, 2008
    Inventors: TIMOTHY P. TULLY, Roderick E. M. Scott, Rusiko Bourtchouladze